Fortis Healthcare files DRHP with SEBI

New Delhi, Oct 3: Fortis Healthcare Ltd, leading pharma company of India, today said it filed its Draft Red Herring Prospectus with the Securities and Exchange Board of India (SEBI) on September 29, with a proposal to enter the capital market.

The company proposes to offer 56.6 crore equity shares of Rs 10 each for cash at a premium to be decided through the 100 per cent book-building process. The company will be listed on the Bombay Stock Exchange and the National Stock Exchange.

Fortis Healthcare also proposes to allot 5 lakh equity shares to eligible employees of the company in the firm allotment portion.

Of the net offer to the public, at least 60 per cent of the offering will be allocated to Qualified Institutional Buyers on a proportionate basis, 5 per cent of which will be available for allotment to mutual funds registered with the SEBI.

Around 10 per cent of the offering will be available for allocation to non-institutional investors while 30 per cent will be available for allocation to retail investors on a proportionate basis.

The Book Running Lead Managers to the issue are JM Morgan Stanley Private Limited, Citigroup Global Markets India Private Limited and Kotak Mahindra Capital Company Limited.

The company currently has a network of 12 hospitals primarily in north India and 15 satellite and heart command centers in hospitals across the country. It has one heart command center in Afghanistan.

The hospitals include multi specialty centres as well as super-specialty 'centers of excellence' providing tertiary and quaternary healthcare to patients in key areas such as cardiac care, orthopedics, neuro-sciences, renal care, pulmono-thoracic surgery and diabetic care.

Besides, the company also manages Fortis La Femme, a 'boutique' style hospital that focuses on women's health and maternity care.

UNI